HematologyNews.net

Hematology Xagena

Search results for "Blood clots"

Researchers at the Mayo Clinic Cancer Center demonstrated that combination therapy with Lenalidomide ( Revlimid ) and Dexamethasone looks like a breakthrough treatment for multiple myeloma. The combi ...


The FDA ( Food and Drug Administration ) has expanded the approved use of Oncaspar ( Peg-Asparaginase ) to include treating children and adults with newly diagnosed acute lymphoblastic leukemia ( ALL ...


The FDA ( Food and Drug Administration ) has approved Xarelto ( Rivaroxaban ) to reduce the risk of blood clots, deep vein thrombosis, and pulmonary embolism following knee or hip replacement surgery. ...


A new analysis has concluded that Rituximab ( MabThera, Rituxan ), a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of ...


A trial evaluating the efficacy and safety of BAY 86-6150 in people with hemophilia A and hemophilia B with inhibitors has been discontinued. The hope that BAY 86-6150 might help patients with inhibit ...


The results of phase III study evaluating a JAK 1/2 inhibitor for the treatment of polycythemia vera were presented at the 50th Annual Meeting of the American Society of Clinical Oncology ( ASCO ). ...


Final data from a phase 2 comparator-controlled study evaluating the incidence of venous thromboembolic events ( VTE ) in patients treated with ISIS-FXI Rx undergoing total knee replacement surgery, o ...